What is Preimplantation Genetic Testing (PGT)?

PGT is a laboratory procedure performed during In Vitro Fertilization (IVF) to screen embryos for genetic abnormalities before implantation.

How big is the Preimplantation Genetic Testing Market?

The global Preimplantation Genetic Testing Market size was estimated at USD 756.6 Million in 2023 and is expected to reach USD 1648.6 Million in 2033.

What is the Preimplantation Genetic Testing Market growth?

The global Preimplantation Genetic Testing Market is expected to grow at a compound annual growth rate of 8.1%. From 2024 To 2033.

Who are the key companies/players in the Preimplantation Genetic Testing Market?

Some of the key players in the Preimplantation Genetic Testing Markets are Quest Diagnostics Incorporated, Natera, Inc., COOPER SURGICAL, INC., Genea Pty Limited., Invitae Corporation, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Bioarray S.L., Illumina, Inc., F. Hoffmann-La Roche Ltd

Why is PGT Important in Assisted Reproductive Technologies (ART)?

PGT enhances the success of ART by identifying genetically healthy embryos, reducing the risk of genetic disorders, and improving overall pregnancy outcomes.

What Drives the Growth of the PGT Market?

Increasing adoption of assisted reproductive technologies, growing awareness about genetic testing, and advancements in testing technologies contribute to the market's growth.

Global Preimplantation Genetic Testing Market By Procedure Type (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis) By Product Type(Reagents and Consumables, Instruments, Software);By Technology(Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Other Technologies)By Application(Chromosomal Abnormalities, Aneuploidy Screening, X-linked Diseases, Other Applications)By End-User(Hospitals, Fertility Centers, Diagnostic Centers,and other) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2033

Published date: July 2024
Report ID: 12405
Number of Pages: 206
Format:

- Quest Diagnostics Incorporated
- Natera, Inc.
- COOPER SURGICAL, INC.
- Genea Pty Limited.
- Invitae Corporation
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific Company Profile
- Bioarray S.L.
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd

Related Reports

Our Clients

Report ID 12405
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (30)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible